NCT00183222View on ClinicalTrials.gov

Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

December 31, 2005

Conditions
Alcohol Dependence
Interventions
DRUG

naltrexone (up to 50 mg/day) for 8 days; ondansetron (0.25 mg twice a day) for 8 days

Trial Locations (1)

29425

Center for Drug and Alcohol Programs, Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Medical University of South Carolina

OTHER

NCT00183222 - Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking | Biotech Hunter | Biotech Hunter